Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) EBT (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed EBT for 10 consecutive years, with -$163.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 222.07% year-over-year to -$163.7 million, compared with a TTM value of -$207.3 million through Dec 2025, up 8.78%, and an annual FY2025 reading of -$207.3 million, down 7.87% over the prior year.
  • EBT was -$163.7 million for Q4 2025 at Global Medical REIT, down from $22.4 million in the prior quarter.
  • Across five years, EBT topped out at $96.3 million in Q4 2023 and bottomed at -$163.7 million in Q4 2025.
  • Average EBT over 5 years is -$28.5 million, with a median of -$12.6 million recorded in 2024.
  • The sharpest move saw EBT tumbled 3166.09% in 2022, then surged 294.07% in 2023.
  • Year by year, EBT stood at -$4.9 million in 2021, then plummeted by 910.05% to -$49.6 million in 2022, then soared by 294.07% to $96.3 million in 2023, then plummeted by 152.75% to -$50.8 million in 2024, then tumbled by 222.07% to -$163.7 million in 2025.
  • Business Quant data shows EBT for GMRE-PB at -$163.7 million in Q4 2025, $22.4 million in Q3 2025, and -$53.7 million in Q2 2025.